MyFinsight
Home
About
Contact
abos: the income statement
Download
Download image
Comprehensive loss
-$26,365K
Unrealized gain on
marketable securities
$86K
Interest income
$1,639K
Net loss
-$26,451K
Total other income
$62K
Other income
(expense), net
-$69K
Change in fair value of
embedded derivatives
-$440K
Interest expense
$1,068K
Loss from operations
-$26,513K
Total operating
expenses
$26,513K
General and
administrative
$4,545K
Research and development
$21,968K
Back
Back
Income Statement
source: myfinsight.com
Acumen Pharmaceuticals, Inc. (ABOS)
Acumen Pharmaceuticals, Inc. (ABOS)